Abstract:The objective of this study was to explore the expression and clinical significance of Notch signaling genes in colorectal cancer. Colorectal cancer samples were prospectively collected from patients post-surgery at the 3rd Affiliated Hospital, Nanjing University of Traditional Chinese Medicine. Immunohistochemistry of tissue arrays was used to analyze the samples and genes involved in the Notch signaling pathway. Microsatellite instability (MSI) was detected by fluorescence multiplex polymerase chain reaction. A total of 146 colorectal cancer samples were collected, including 84 men (57.7%) and 62 women (42.5%). The average age of the study population was 60.8 ± 10.5 years. Notch1 and Notch2 gene expression correlated with tumor pathology type and degree of differentiation. In addition, Jagged 1 (JAG1) and hairy enhancer of split 1 gene expression correlated with the degree of tumor differentiation. Delta-like 1 gene expression varied significantly with tumor location. There was a significant difference between gene expression and MSI. Of the 138 patients, 134 (91.8%) participated in on-site visits, and the average follow-up time was 42.3 ± 13.3 months. During this period, 86 patients (71.6%) were tumor-free. At 1 year post-surgery, 93% of patients were alive, 74% of patients lived for 3 years, and 67% of patients lived for 5 years. The log-rank test was used to perform univariate analysis, and the COX proportional hazards model was used for the multivariate analysis. Based on these analyses, tumor prognosis correlated with the TNM stage, pathological type, microsatellite status as well as Notch2 and JAG1 gene expression. Patients expressing high levels of Notch2 and JAG1 presented with a significantly better prognosis compared to patients expressing negative or weak levels of Notch2 and JAG1. The expression levels of genes associated with the Notch signaling pathway correlated with tumor pathology and the degree of differentiation. In addition, Notch2 and JAG1 expression levels correlated with survival; however, the underlying mechanism for these correlations remains unclear.

Expression of Jagged 1 Predicts Postoperative Clinical Outcome of Patients with Gastric Cancer

Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.

High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma

Evaluation of Jagged2 and Gli1 expression and their correlation with prognosis in human hepatocellular carcinoma.

Identification of Genes Associated with Gastric Cancer Survival and Construction of a Nomogram to Improve Risk Stratification for Patients with Gastric Cancer.

Notch1 Activation is a Poor Prognostic Factor in Patients with Gastric Cancer

Expression and Clinical Significance of Notch Signaling Genes in Colorectal Cancer

Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer.

Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer

Expression of Inos,mmp-2 and Notch1 in Gastric Cancer and Their Correlation with Metastasis

Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling

Expression of Notch-1 and Jagged-1 Protein in Human Colorectal Cancer and It's Significance

Correlation between Expression of Notch1 and Jagged1 and Carcinogenesis and Prognosis of Clear Cell Renal Cell Carcinoma

Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression

Expression of Jagged1/Notch3 Signaling Pathway and Their Relationship with the Tumor Angiogenesis in TNBC

Notch Signaling Pathway and Clinicopathology in Human Gastric Cancer

Expression and Relationship of Notch 1,Jagged1 and COX-2 in Gastric Cancer

Expression and Significance of Notch1,Jagged1 and NF-κB in Human Gastric Carcinoma

Expressions and clinical significance of Notch-1 and Jagged-1 in bladder transitional cell carcinoma tissues

Increased Expression of C-C Motif Ligand 2 Associates with Poor Prognosis in Patients with Gastric Cancer after Gastrectomy

Elevated JMJD1A is a Novel Predictor for Prognosis and a Potential Therapeutic Target for Gastric Cancer.